Eversept Partners’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-2,657
Closed -$413K – 84
2022
Q1
$413K Hold
2,657
– – 0.03% 82
2021
Q4
$640K Hold
2,657
– – 0.04% 96
2021
Q3
$1.14M Buy
+2,657
New +$1.22M 0.08% 94
2020
Q3
– Sell
-1,769
Closed -$1.46M – 54
2020
Q2
$1.46M Sell
1,769
-639
-27% -$374K 0.2% 54
2020
Q1
$893K Buy
+2,408
New +$1.2M 0.22% 45
2019
Q3
– Sell
-135
Closed -$217K – 60
2019
Q2
$217K Buy
+135
New +$267K 0.06% 61

Other funds holding KRSA

Eversept Partners's KRSA Position: Q2 2022 in Review

Eversept Partners sold out of Korsana Biosciences (KRSA) in Q2 2022, closing a stake of 2,657 shares — an estimated $413K sold.

Eversept Partners first reported a position in KRSA in Q2 2019 and held it in 6 quarters. The position peaked at $1.46M in Q2 2020. 36 funds tracked by Wall St. Rank hold KRSA as of Q2 2022.

  • Eversept Partners reported no remaining Korsana Biosciences position as of Q2 2022 after selling out during the quarter.
  • Eversept Partners sold 2,657 Korsana Biosciences shares in Q2 2022, an estimated $413K.
  • Eversept Partners first reported a position in Korsana Biosciences in Q2 2019 and held it in 6 quarters.
  • Eversept Partners's Korsana Biosciences position peaked at $1.46M in Q2 2020.
  • 36 funds tracked by Wall St. Rank held Korsana Biosciences as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.